Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $3.3 million.

  • InflaRx's Other Non Operating Income rose 20566.03% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 15198.45%. This contributed to the annual value of $4.0 million for FY2024, which is 30045.15% up from last year.
  • InflaRx's Other Non Operating Income amounted to $3.3 million in Q3 2025, which was up 20566.03% from -$3.2 million recorded in Q2 2025.
  • InflaRx's Other Non Operating Income's 5-year high stood at $889.7 billion during Q3 2022, with a 5-year trough of -$1220.7 billion in Q1 2023.
  • For the 4-year period, InflaRx's Other Non Operating Income averaged around -$22.1 billion, with its median value being $816986.6 (2022).
  • Per our database at Business Quant, InflaRx's Other Non Operating Income tumbled by 14941777234.18% in 2023 and then surged by 20566.03% in 2025.
  • InflaRx's Other Non Operating Income (Quarter) stood at -$746398.6 in 2022, then tumbled by 442.75% to -$4.1 million in 2023, then soared by 205.04% to $4.3 million in 2024, then dropped by 22.35% to $3.3 million in 2025.
  • Its Other Non Operating Income was $3.3 million in Q3 2025, compared to -$3.2 million in Q2 2025 and -$2.0 million in Q1 2025.